Call to Schedule Free Consultation at Over 80 Centers Worldwide!
Autoimmune
Cardiovascular
Endocrine
Gastrointestinal
Liver
Musculoskeletal
Neurological
Other
Respiratory/Pulmonary
Reproductive
Renal/Kidney
Urologic
Autoimmune
Cardiovascular
Endocrine
Gastrointestinal
Liver
Musculoskeletal
Neurological
Other
Respiratory/Pulmonary
Reproductive
Renal/Kidney
Urologic
Written by Dr. David Greene, MD, PhD, MBA on May 22, 2026
For parents considering stem cell therapy for a child with autism or cerebral palsy, one of the most pressing questions is whether sedation is safe. A recently published study offers meaningful reassurance — and it aligns with over a decade of clinical practice at R3 Stem Cell.
A study published in the peer-reviewed journal Anesthesiology News examined whether short-duration exposure to anesthetic gases causes any measurable harm to children’s developing brains. Specifically, researchers looked at language development, behavioral outcomes, and cognitive function.
The study, conducted in South Korea, enrolled 170 children who underwent brief procedures using anesthetic gas. Researchers then followed these children for two and a half years to assess any lasting effects.
The conclusion was clear: no significant negative outcomes were found across the language, behavioral, or cognitive measures studied.
This finding is particularly meaningful because it addresses a concern raised by earlier animal studies, which had suggested the possibility of neurological effects from anesthetic gas exposure. Those studies created uncertainty among parents and providers alike. This new human clinical data provides important clarification — short-duration anesthetic sedation in children does not appear to cause lasting harm.
It is worth noting that research in this area continues to evolve. While this study is reassuring, parents should always discuss individual risk factors with their child’s medical team before any procedure involving sedation.
Children — especially those with autism spectrum disorder (ASD) or cerebral palsy — often cannot remain still long enough for the precise procedures required during stem cell therapy. Conscious sedation using anesthetic gas allows the medical team to safely administer treatment while keeping the child comfortable and free from distress.
Stem cell therapy for autism and cerebral palsy may involve intravenous (IV) delivery of stem cells and exosomes, and in some cases an intrathecal injection — meaning delivery directly into the spinal fluid. This latter approach requires the child to remain still and is not feasible without sedation.
Dr. David Greene, founder and CEO of R3 Stem Cell, describes the process as highly structured, closely monitored, and family-inclusive. Here is what the procedure typically involves:
Phase | What Happens | Timeframe |
Sedation onset | An anesthesiologist administers gas; the child falls asleep | 15–30 seconds |
IV placement | Team places IV line for stem cell and exosome infusion | 2–5 minutes |
Treatment delivery | IV stem cells, exosomes administered; intrathecal injection if indicated | ~20 minutes |
Recovery | Gas stopped; the child woke naturally | 5–10 minutes |
Total procedure time | Under 30–45 minutes |
Safety is maintained through continuous monitoring of:
Oxygen saturation — to ensure adequate breathing
Blood pressure — tracked throughout sedation
Heart rate — monitored for any irregularities
A licensed anesthesiologist oversees the entire sedation process, and a parent or guardian is welcome to remain in the room to provide comfort and reassurance to their child.
Once the anesthetic gas is discontinued, most children wake within five to ten minutes. They are typically drowsy afterward, which naturally encourages rest — an important part of early recovery. Based on R3 Stem Cell’s clinical experience spanning more than ten years and thousands of pediatric cases, no persistent side effects from the anesthetic gases have been observed.
For some children, particularly those with autism or neurological conditions, intrathecal stem cell delivery is recommended as part of the treatment protocol. This involves injecting stem cells directly into the cerebrospinal fluid, which surrounds the brain and spinal cord, allowing cells to reach the central nervous system more directly.
This delivery method is considered more targeted for neurological conditions and is only performed under sedation. It adds approximately 10 to 15 minutes to the overall procedure time. Learn more about how stem cell therapy works for autism and what outcomes current research supports.
R3 Stem Cell’s international clinics offer conscious sedation-assisted stem cell therapy for a range of pediatric neurological and developmental conditions, including:
Autism Spectrum Disorder (ASD) — one of the most commonly treated conditions in children
Cerebral Palsy — where stem cells may support neurological function and reduce inflammation
Other conditions where IV and intrathecal stem cell delivery may be clinically appropriate
R3 currently operates clinics in eight countries. Conscious sedation is available at all international locations. Within the United States, sedation protocols differ due to regulatory frameworks, and providers follow applicable state and federal guidelines.
Not every child is an immediate candidate for stem cell therapy. Eligibility depends on the child’s diagnosis, overall health, age, and specific treatment goals. R3 Stem Cell offers consultations to help families understand whether their child may benefit from regenerative therapy and what a personalized protocol might look like.
If you are exploring options for a child with autism, cerebral palsy, or another neurological condition, speaking with a qualified regenerative medicine provider is an important first step. You can also review frequently asked questions about stem cell therapy to better understand what to expect before, during, and after treatment.
Contact Us
Consent alone is not sufficient. Donor mothers also undergo comprehensive medical screening, which typically includes: